{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:05:19Z","timestamp":1777860319661,"version":"3.51.4"},"reference-count":51,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Risk &amp; Safety in Medicine"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>People living with Human Immunodeficiency Virus (PLW-HIV) on anti-retroviral therapy are more likely to develop tuberculosis as compared to people without HIV. The objective of the study is to evaluate the risk factors, prevalence, and management pattern of Anti-tubercular therapy-induced hepatitis (ATT-IH) in PLW-HIV with Anti-Retroviral Therapy (ART) in comparison with HIV-SNP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>\n                      A retrospective observational cohort study was conducted at a university teaching hospital for Anti-tubercular therapy-induced hepatitis ATT-IH. Patients were screened based on International Classification of Diseases codes 10. A total of N = 431 patients with ATT-IH (250 males and 181 females) were included in the study. The severity grading of ATT-IH was assessed by Liver Tox. The risk factors associated with ATT-IH in HIV-SPP and HIV-SNP were assessed and determined at a\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      value &lt;0.05.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 431 patients with ATT-IH, 231 patients experienced ATT-IH in the HIV-SP group and 200 patients in the HIV-SN group. Zero-inflated regression analysis identified risk factors for ATT-IH in HIV-SPP in comparison with HIV-SNP, including BMI, hepatitis B, and smoking habits. The prevalence of ATT-IH in HIV-SPP was 53.6% and 46.4% in HIV-SNP. A higher incidence of 23 (10 %) of ATT-IH was reported with the Tenofovir + Lamivudine + Lopinavir+ Ritonavir ART regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Clinicians must focus on early detection of risk factors for ATT-IH in HIV-SPP in comparison with HIV-SNP to prevent significant hepatic complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09246479251401359","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T17:12:58Z","timestamp":1764004378000},"page":"131-143","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors associated with anti-tubercular therapy-induced hepatitis in human immunodeficiency virus seropositive and seronegative patients in India"],"prefix":"10.1177","volume":"37","author":[{"given":"Aneez","family":"Jamal KM","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1369-4256","authenticated-orcid":false,"given":"Ashutosh","family":"Bhosale","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muralidhar","family":"Varma","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9904-7946","authenticated-orcid":false,"given":"Rajesh","family":"Radhakrishnan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"e_1_3_6_2_2","volume-title":"Global tuberculosis report","year":"2023","unstructured":"Global tuberculosis report 2023. World Health Organization. https:\/\/iris.who.int\/bitstream\/handle\/10665\/373828\/9789240083851-eng.pdf?sequence=1"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/2150131916642431"},{"key":"e_1_3_6_4_2","volume-title":"National guidelines for management of drug resistant TB","author":"Central TB Division MoHaFW, Government of India","year":"2025","unstructured":"Central TB Division MoHaFW, Government of India. National guidelines for management of drug resistant TB. Government of India, 2025."},{"key":"e_1_3_6_5_2","volume-title":"Drug Sensitive-TB treatment as per NTEP adult TB guidelines","author":"Research ICM","year":"2022","unstructured":"Research ICM. Drug Sensitive-TB treatment as per NTEP adult TB guidelines. Indian Council of Medical Research, 2022."},{"key":"e_1_3_6_6_2","volume-title":"Directorate general of health services","author":"Ministry of Health and Family Welfare GoI","year":"2024","unstructured":"Ministry of Health and Family Welfare GoI. National tuberculosis elimination programme. Directorate general of health services. Government of India, 2024."},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S290542"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.3233\/JRS-130580"},{"key":"e_1_3_6_9_2","unstructured":"WHO HIV\/AIDS Programme. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection Recommendation for a public health approach. 2nd ed. 2016. [Available from]: https:\/\/www.who.int\/hiv\/pub\/arv\/arv-2016\/en\/"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157725"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12981-016-0106-y"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2004.00758.x"},{"key":"e_1_3_6_13_2","first-page":"47","article-title":"Hepatotoxicity in HIV patients, an observational study in patients from tertiary care centre of Western India","volume":"65","author":"Bajpai S","year":"2017","unstructured":"Bajpai S, Joshi K. Hepatotoxicity in HIV patients, an observational study in patients from tertiary care centre of Western India. J Assoc Phys India 2017; 65: 47\u201349.","journal-title":"J Assoc Phys India"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.5604\/16652681.1171778"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.06.020"},{"key":"e_1_3_6_16_2","first-page":"153","article-title":"Tuberculosis: a resurgent disease in immunosuppressed patients","volume":"37","author":"Nissapatorn V","year":"2006","unstructured":"Nissapatorn V, Kuppusamy I, Josephine F, et al. Tuberculosis: a resurgent disease in immunosuppressed patients. Southeast Asian J Trop Med Publ Health 2006; 37: 153\u2013160.","journal-title":"Southeast Asian J Trop Med Publ Health"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2015.10.001"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.4103\/0975-1483.104369"},{"key":"#cr-split#-e_1_3_6_19_2.1","unstructured":"International classification of disease (ICD)-10-Volume-1 [homepage on the Internet]. [Updated 2013 June 17"},{"key":"#cr-split#-e_1_3_6_19_2.2","unstructured":"cited 2017 July 5]. Available from: https:\/\/www.cdc.gov\/nchs\/data\/dvs\/2e_volume1_2013.pdf"},{"key":"e_1_3_6_20_2","volume-title":"Clinical and research information on drug-Induced liver injury","year":"2017","unstructured":"Clinical and research information on drug-Induced liver injury, United States national library of Medicine [Internet]. 2017. Available from: https:\/\/livertox.nih.gov\/Severity.html"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064622"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0377-1237(06)80155-3"},{"issue":"12","key":"e_1_3_6_23_2","first-page":"1499","article-title":"The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity","volume":"8","author":"Fernandez-Villar A","year":"2004","unstructured":"Fernandez-Villar A, Sopena B, Fernandez-Villar J, et al. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity. Int J Tubercul Lung Dis 2004; 8(12): 1499\u20131505.","journal-title":"Int J Tubercul Lung Dis"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.107003"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-016-0676-6"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2011.0247"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07838-w"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001574"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2016.12.002"},{"issue":"1","key":"e_1_3_6_30_2","first-page":"8266878","article-title":"Incidence and temporal trend of antituberculosis drug\u2010induced liver injury: a systematic review and meta\u2010analysis","volume":"2022","author":"Wang N","year":"2022","unstructured":"Wang N, Chen X, Hao Z, et al. Incidence and temporal trend of antituberculosis drug\u2010induced liver injury: a systematic review and meta\u2010analysis. J Trop Med 2022; 2022(1): 8266878.","journal-title":"J Trop Med"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2108091"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/381499"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmyco.2016.05.003"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2330-z"},{"key":"e_1_3_6_35_2","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2016.25.167.10060"},{"issue":"1","key":"e_1_3_6_36_2","first-page":"78","article-title":"Incidence of and risk factors for severe liver toxicity in HIV-Infected patients on anti-tuberculosis treatment","volume":"11","author":"Pukenyte E","year":"2007","unstructured":"Pukenyte E, Lescure F-X, Rey D, et al. Incidence of and risk factors for severe liver toxicity in HIV-Infected patients on anti-tuberculosis treatment. Int J Tubercul Lung Dis 2007; 11(1): 78\u201384.","journal-title":"Int J Tubercul Lung Dis"},{"key":"e_1_3_6_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001587"},{"key":"e_1_3_6_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.03.003"},{"key":"e_1_3_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32814e6b08"},{"key":"e_1_3_6_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05207.x"},{"key":"e_1_3_6_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3988"},{"key":"e_1_3_6_42_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200911-1783OC"},{"key":"e_1_3_6_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31682-5"},{"key":"e_1_3_6_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094271"},{"key":"e_1_3_6_45_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000135956.96166.f0"},{"key":"e_1_3_6_46_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0831"},{"key":"e_1_3_6_47_2","doi-asserted-by":"publisher","DOI":"10.4102\/sajhivmed.v25i1.1558"},{"key":"e_1_3_6_48_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-023-04988-0"},{"key":"e_1_3_6_49_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18105165"},{"key":"e_1_3_6_50_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0111"},{"key":"e_1_3_6_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2021.03.003"}],"container-title":["International Journal of Risk &amp; Safety in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09246479251401359","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09246479251401359","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09246479251401359","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:45:52Z","timestamp":1777509952000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09246479251401359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1177\/09246479251401359"],"URL":"https:\/\/doi.org\/10.1177\/09246479251401359","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/09246479251401359\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479251401359\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479251401359\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479251401359\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479251401359\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479251401359\/v3\/decision1","asserted-by":"object"}]},"ISSN":["0924-6479","1878-6847"],"issn-type":[{"value":"0924-6479","type":"print"},{"value":"1878-6847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,24]]}}}